Join
Live feed
·
INSIDERFilingvia Quantisnow
Clovis Oncology Inc. logo

SEC Form 4: Gross Paul Edward converted options into 5,063 shares and sold $2,770 worth of shares (2,308 units at $1.20), increasing direct ownership by 3% to 92,812 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLVS (Clovis Oncology Inc.) and more on Quantisnow.

SEC Form 4: Gross Paul Edward converted options into 5,063 shares and sold $2,770 worth of shares (2,308 units at $1.20), increasing direct ownership by 3% to 92,812 units to satisfy tax liability | Quantisnow